Kura Oncology Ownership 2024 | Who Owns Kura Oncology Now?
Institutional Ownership
9.35%
Insider Ownership
1.07%
Retail Ownership
89.59%
Institutional Holders
52.00
Kura Oncology Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 8.43% | 5.35% | 7,069,627 | - | - | 145,563,620 | Jun 30, 2024 |
| BLACKROCK INC. | 8.30% | 0.00% | 6,965,806 | 66,437 | 0.96% | 143,425,947 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 6.92% | 3.66% | 5,806,871 | - | - | 119,563,474 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6.45% | 1.85% | 5,411,571 | - | - | 111,424,247 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 5.41% | 3.58% | 4,539,381 | 1,403,994 | 44.78% | 93,465,855 | Jun 30, 2024 |
| BVF INC/IL | 4.87% | 2.36% | 4,082,037 | -704,256 | -14.71% | 84,049,142 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.82% | 0.00% | 4,040,456 | -25,447 | -0.63% | 83,192,989 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 4.22% | 0.97% | 3,541,505 | -308,495 | -8.01% | 72,919,588 | Jun 30, 2024 |
| STATE STREET CORP | 3.44% | 0.00% | 2,884,541 | -1,315,413 | -31.32% | 59,392,699,000 | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | 3.21% | 0.23% | 2,689,456 | 251,993 | 10.34% | 55,375,899 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 2.80% | 0.61% | 2,350,000 | 302,000 | 14.75% | 48,386,500 | Jun 30, 2024 |
| FORESITE CAPITAL MANAGEMENT IV, LLC | 2.20% | 25.59% | 1,849,947 | - | - | 38,090,409 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 2.17% | 0.96% | 1,819,884 | -100,000 | -5.21% | 37,471,412 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.07% | 0.00% | 1,738,974 | 31,700 | 1.86% | 35,812,999 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 2.06% | 0.08% | 1,731,577 | 577,732 | 50.07% | 35,653,170 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 1.90% | 2.24% | 1,593,350 | 68,350 | 4.48% | 32,807,077 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 1.87% | 0.01% | 1,565,288 | -9,958 | -0.63% | 32,229,284 | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 1.70% | 3.06% | 1,423,642 | - | - | 29,312,789 | Jun 30, 2024 |
| MORGAN STANLEY | 1.58% | 0.00% | 1,328,514 | -28,947 | -2.13% | 27,354,118 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 1.19% | 1.08% | 1,000,000 | - | - | 20,590,000 | Jun 30, 2024 |
Kura Oncology's largest institutional shareholder is SUVRETTA CAPITAL MANAGEMENT, LLC, holding 8.43% of the company's total share outstanding, currently valued at $145.56M. The top 10 institutional shareholders own together 56.05% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FORESITE CAPITAL MANAGEMENT IV, LLC | 2.20% | 25.59% | 1,849,947 | - | - | 38,090,409 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 8.43% | 5.35% | 7,069,627 | - | - | 145,563,620 | Jun 30, 2024 |
| ALETHEA CAPITAL MANAGEMENT, LLC | 0.32% | 4.15% | 265,906 | 6,300 | 2.43% | 5,475,005 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 0.75% | 3.88% | 629,900 | -330,100 | -34.39% | 12,969,641 | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | 0.37% | 3.76% | 306,762 | -58,282 | -15.97% | 6,316,230 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 6.92% | 3.66% | 5,806,871 | - | - | 119,563,474 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 5.41% | 3.58% | 4,539,381 | 1,403,994 | 44.78% | 93,465,855 | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 1.70% | 3.06% | 1,423,642 | - | - | 29,312,789 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 0.19% | 2.83% | 163,000 | 73,000 | 81.11% | 3,356,170 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.16% | 2.36% | 131,742 | 131,742 | 100.00% | 2,712,568 | Jun 30, 2024 |
| BVF INC/IL | 4.87% | 2.36% | 4,082,037 | -704,256 | -14.71% | 84,049,142 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 1.90% | 2.24% | 1,593,350 | 68,350 | 4.48% | 32,807,077 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.50% | 2.08% | 423,500 | 10,837 | 2.63% | 8,719,865 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6.45% | 1.85% | 5,411,571 | - | - | 111,424,247 | Jun 30, 2024 |
| PROPEL BIO MANAGEMENT, LLC | 0.15% | 1.74% | 130,000 | - | - | 2,676,700 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.73% | 1.72% | 610,826 | - | - | 12,576,907 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.77% | 1.54% | 650,000 | -80,492 | -11.02% | 13,383,500 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 1.19% | 1.08% | 1,000,000 | - | - | 20,590,000 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 4.22% | 0.97% | 3,541,505 | -308,495 | -8.01% | 72,919,588 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 2.17% | 0.96% | 1,819,884 | -100,000 | -5.21% | 37,471,412 | Jun 30, 2024 |
The largest Kura Oncology shareholder by % of total assets is FORESITE CAPITAL MANAGEMENT IV, LLC. The company owns 1.85M shares of Kura Oncology (KURA), representing 25.59% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PARADIGM BIOCAPITAL ADVISORS LP | 5.41% | 3.58% | 4,539,381 | 1,403,994 | 44.78% | 93,465,855 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 2.06% | 0.08% | 1,731,577 | 577,732 | 50.07% | 35,653,170 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 0.46% | 0.24% | 384,756 | 384,756 | 100.00% | 7,922,126 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 0.98% | 0.88% | 825,243 | 323,303 | 64.41% | 16,991,753 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 2.80% | 0.61% | 2,350,000 | 302,000 | 14.75% | 48,386,500 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 1.08% | 0.11% | 906,482 | 255,065 | 39.16% | 18,663,594 | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | 3.21% | 0.23% | 2,689,456 | 251,993 | 10.34% | 55,375,899 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.22% | 0.00% | 182,557 | 182,557 | 100.00% | 3,758,842 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.17% | 0.03% | 143,207 | 143,207 | 100.00% | 2,948,632 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.16% | 2.36% | 131,742 | 131,742 | 100.00% | 2,712,568 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.12% | 0.20% | 100,000 | 100,000 | 100.00% | 2,059,000 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.32% | 0.01% | 272,274 | 94,624 | 53.26% | 5,606,122 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 0.19% | 2.83% | 163,000 | 73,000 | 81.11% | 3,356,170 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 0.09% | 0.10% | 72,317 | 72,317 | 100.00% | 1,489,007 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 1.90% | 2.24% | 1,593,350 | 68,350 | 4.48% | 32,807,077 | Jun 30, 2024 |
| BLACKROCK INC. | 8.30% | 0.00% | 6,965,806 | 66,437 | 0.96% | 143,425,947 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.10% | 0.00% | 81,655 | 58,422 | 251.46% | 1,681,276 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.09% | 0.00% | 77,475 | 54,051 | 230.75% | 1,595,211 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.31% | 0.00% | 262,051 | 51,885 | 24.69% | 5,395,631 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.99% | 0.00% | 831,885 | 46,009 | 5.85% | 17,128,512 | Jun 30, 2024 |
As of Jun 30 2024, Kura Oncology's largest institutional buyer is PARADIGM BIOCAPITAL ADVISORS LP. The company purchased 1.40M stocks of KURA, valued at $93.47M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STATE STREET CORP | 3.44% | 0.00% | 2,884,541 | -1,315,413 | -31.32% | 59,392,699,000 | Jun 30, 2024 |
| BVF INC/IL | 4.87% | 2.36% | 4,082,037 | -704,256 | -14.71% | 84,049,142 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | - | - | - | -700,000 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.07% | 0.00% | 894,619 | -468,816 | -34.38% | 18,420,219 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 0.75% | 3.88% | 629,900 | -330,100 | -34.39% | 12,969,641 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 4.22% | 0.97% | 3,541,505 | -308,495 | -8.01% | 72,919,588 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | - | - | - | -300,000 | -100.00% | - | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.15% | 0.01% | 124,585 | -186,683 | -59.98% | 2,565,205 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.23% | 0.02% | 190,009 | -171,811 | -47.49% | 3,912,285 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.40% | 0.00% | 339,482 | -148,734 | -30.46% | 6,989,934 | Jun 30, 2024 |
| UBS GROUP AG | 0.11% | 0.00% | 91,777 | -135,044 | -59.54% | 1,889,688 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.14% | 0.00% | 121,200 | -119,000 | -49.54% | 2,495,508 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -109,161 | -100.00% | - | Jun 30, 2024 |
| ARTAL GROUP S.A. | 2.17% | 0.96% | 1,819,884 | -100,000 | -5.21% | 37,471,412 | Jun 30, 2024 |
| INVESCO LTD. | 0.27% | 0.00% | 229,199 | -84,873 | -27.02% | 4,719,207 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.77% | 1.54% | 650,000 | -80,492 | -11.02% | 13,383,500 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.02% | 0.00% | 16,319 | -78,969 | -82.87% | 336,008 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.48% | 0.00% | 402,563 | -78,059 | -16.24% | 8,288,773 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.05% | 0.00% | 42,612 | -66,543 | -60.96% | 877,381 | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -58,967 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Kura Oncology's biggest institutional seller is STATE STREET CORP. The company sold -1.32M shares of KURA, valued at $59.39B.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DEEP TRACK CAPITAL, LP | 0.46% | 0.24% | 384,756 | 384,756 | 100.00% | 7,922,126 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.22% | 0.00% | 182,557 | 182,557 | 100.00% | 3,758,842 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.17% | 0.03% | 143,207 | 143,207 | 100.00% | 2,948,632 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.16% | 2.36% | 131,742 | 131,742 | 100.00% | 2,712,568 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.12% | 0.20% | 100,000 | 100,000 | 100.00% | 2,059,000 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 0.09% | 0.10% | 72,317 | 72,317 | 100.00% | 1,489,007 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 40,484 | 40,484 | 100.00% | 833,143 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 39,010 | 39,010 | 100.00% | 803,216 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.04% | 0.94% | 36,242 | 36,242 | 100.00% | 746,223 | Jun 30, 2024 |
| J. GOLDMAN & CO LP | 0.04% | 0.02% | 32,721 | 32,721 | 100.00% | 673,725 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.03% | 0.00% | 26,267 | 26,267 | 100.00% | 540,838 | Jun 30, 2024 |
| FOX RUN MANAGEMENT, L.L.C. | 0.03% | 0.09% | 24,340 | 24,340 | 100.00% | 501,161 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.03% | 0.03% | 23,700 | 23,700 | 100.00% | 487,983 | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.02% | 0.13% | 16,764 | 16,764 | 100.00% | 345,171 | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | 0.02% | 0.00% | 13,517 | 13,517 | 100.00% | 278,315 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.01% | 0.00% | 11,300 | 11,300 | 100.00% | 232,667 | Jun 30, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | 0.01% | 0.00% | 10,500 | 10,500 | 100.00% | 216,195 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 0.01% | 0.00% | 10,000 | 10,000 | 100.00% | 205,900 | Jun 30, 2024 |
| KNOTT DAVID M JR | 0.01% | 0.08% | 10,000 | 10,000 | 100.00% | 206,000 | Jun 30, 2024 |
| QUARRY LP | 0.01% | 0.05% | 9,500 | 9,500 | 100.00% | 195,605 | Jun 30, 2024 |
| CWM, LLC | 0.00% | 0.00% | 534 | 534 | 100.00% | 11,000 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 185 | 185 | 100.00% | 3,792 | Jun 30, 2024 |
| PARALLEL ADVISORS, LLC | 0.00% | 0.00% | 172 | 172 | 100.00% | 3,541 | Jun 30, 2024 |
| GLOBAL RETIREMENT PARTNERS, LLC | 0.00% | 0.00% | 142 | 142 | 100.00% | 2,924 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | 0.00% | 54 | 54 | 100.00% | 1,112 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | - | 0.00% | 26 | 26 | 100.00% | 536 | Jun 30, 2024 |
| MASSMUTUAL TRUST CO FSB/ADV | - | - | 19 | 19 | 100.00% | 391,000 | Jun 30, 2024 |
Kura Oncology's largest new institutional shareholder by number of shares is DEEP TRACK CAPITAL, LP, purchased 384.76K shares, valued at $7.92M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ECOR1 CAPITAL, LLC | - | - | - | -700,000 | -100.00% | - | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | - | - | - | -300,000 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -109,161 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -58,967 | -100.00% | - | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | - | - | - | -48,200 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -35,548 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -34,775 | -100.00% | - | Jun 30, 2024 |
| CINCTIVE CAPITAL MANAGEMENT LP | - | - | - | -29,543 | -100.00% | - | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | - | - | - | -23,754 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -23,746 | -100.00% | - | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | - | - | - | -18,079 | -100.00% | - | Jun 30, 2024 |
| GTS SECURITIES LLC | - | - | - | -17,200 | -100.00% | - | Jun 30, 2024 |
| E FUND MANAGEMENT CO., LTD. | - | - | - | -14,710 | -100.00% | - | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | - | - | - | -13,339 | -100.00% | - | Jun 30, 2024 |
| ENTROPY TECHNOLOGIES, LP | - | - | - | -10,215 | -100.00% | - | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | - | - | - | -10,172 | -100.00% | - | Jun 30, 2024 |
| SAXON INTERESTS, INC. | - | - | - | -9,420 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -5,174 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -3,719 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -2,125 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -14 | -100.00% | - | Jun 30, 2024 |
Kura Oncology's largest sold out institutional shareholder by shares sold is ECOR1 CAPITAL, LLC, sold -0.70M shares, valued at -, as of undefined.
Kura Oncology Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| HARTFORD HLS SERIES FUND II INC | 1.00% | 245,172 | - | - | Dec 31, 2023 |
| WANGER ADVISORS TRUST | 0.65% | 356,018 | - | - | Mar 31, 2024 |
| COLUMBIA ACORN TRUST | 0.41% | 1,322,863 | - | - | Mar 31, 2024 |
| EntrepreneurShares Series Trust | 0.23% | 62,331 | - | - | Dec 31, 2023 |
| TEKLA HEALTHCARE INVESTORS | 0.23% | 198,177 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.19% | 683,167 | - | - | Mar 31, 2024 |
| Nuveen NASDAQ 100 Dynamic Overwrite Fund | 0.19% | 22,160 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.18% | 85,104 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.16% | 1,318,600 | - | - | Jan 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.11% | 953,782 | 203,790 | 27.17% | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.10% | 50,715 | - | - | Mar 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.09% | 45,190 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.08% | 637,118 | - | - | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.07% | 13,769 | 13,769 | - | Mar 28, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.07% | 180,000 | - | - | Mar 31, 2024 |
| AIM EQUITY FUNDS (INVESCO EQUITY FUNDS) | 0.04% | 471,600 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY GROWTH FUNDS, INC. | 0.03% | 5,265 | - | - | Jan 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.03% | 341,160 | - | - | Mar 31, 2024 |
| AIM SECTOR FUNDS (INVESCO SECTOR FUNDS) | 0.02% | 505,575 | - | - | Jan 31, 2024 |
| Federated Hermes MDT Series | 0.02% | 51,149 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 123,977 | -5,789 | -4.46% | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.02% | 595,440 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 10,658 | -247 | -2.27% | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.02% | 52,658 | 837 | 1.62% | Feb 29, 2024 |
| Humankind Benefit Corp | 0.01% | 320 | - | - | Dec 31, 2023 |
| Vericimetry Funds | 0.01% | 1,020 | - | - | Mar 31, 2024 |
| Listed Funds Trust | 0.01% | 53,683 | - | - | Mar 31, 2024 |
| UBS FUNDS | 0.01% | 46,081 | - | - | Mar 31, 2024 |
| AIM COUNSELOR SERIES TRUST (INVESCO COUNSELOR SERIES TRUST) | 0.01% | 2,206,832 | - | - | Feb 29, 2024 |
| FIDELITY SECURITIES FUND | 0.01% | 868,126 | - | - | Jan 31, 2024 |
| Nushares ETF Trust | 0.01% | 62,374 | - | - | Jan 31, 2024 |
| North Square Investments Trust | 0.01% | 80,930 | 27,340 | 51.02% | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 3,351,705 | -1,189,313 | -26.19% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,654 | - | - | Mar 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.01% | 350,000 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.01% | 50,300 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 41,351 | 15,404 | 59.37% | Aug 31, 2023 |
| Brown Advisory Funds | 0.01% | 203,042 | - | - | Mar 31, 2024 |
| JNL VARIABLE FUND LLC | 0.00% | 28,045 | - | - | Mar 31, 2020 |
| ETFis Series Trust I | 0.00% | 6,867 | -1,757 | -20.37% | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 199,788 | 9,273 | 4.87% | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 100,000 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 54,515 | 2,075 | 3.96% | Feb 29, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 36,975 | - | - | Mar 28, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.00% | 105,264 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 712,179 | 620 | 0.09% | Feb 29, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 523,800 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 7,304 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 30,731 | 317 | 1.04% | Mar 31, 2024 |
| JPMORGAN INSURANCE TRUST | 0.00% | 32,107 | -1,343 | -4.01% | Mar 31, 2023 |
| CARILLON SERIES TRUST | 0.00% | 119,499 | - | - | Mar 31, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 29,812 | - | - | Feb 29, 2024 |
| FORUM FUNDS II | 0.00% | 2,000 | - | - | Jan 31, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 81,153 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 34,847 | -404 | -1.15% | Mar 31, 2024 |
| AMG FUNDS III | 0.00% | 9,556 | - | - | Mar 28, 2024 |
| Simplify Exchange Traded Funds | 0.00% | 80,000 | - | - | Mar 28, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 44,901 | -3,415 | -7.07% | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 3,265 | -22,393 | -87.27% | Feb 29, 2024 |
| MML SERIES INVESTMENT FUND | 0.00% | 13,352 | - | - | Dec 31, 2023 |
| ProFunds | 0.00% | 16,351 | 7,277 | 80.20% | Mar 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 143,047 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 537,565 | 20,200 | 3.90% | Jan 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 4,852 | 3,038 | 167.48% | Mar 31, 2024 |
| Meeder Funds | 0.00% | 5,069 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 1,070,993 | 83,713 | 8.48% | Jan 31, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 155,866 | - | - | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 145,238 | -37,125 | -20.36% | Jan 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 437 | - | - | Apr 30, 2021 |
| Principal Exchange-Traded Funds | 0.00% | 9,668 | -794 | -7.59% | Mar 31, 2024 |
| NEW COVENANT FUNDS | 0.00% | 3,438 | - | - | Dec 31, 2023 |
| ETF Series Solutions | 0.00% | 16,678 | 2,672 | 19.08% | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 84,470 | 29,740 | 54.34% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 23,424 | -5,735 | -19.67% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 176,608 | -12,548 | -6.63% | Feb 29, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 395,277 | 17,331 | 4.59% | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 3,281 | -58 | -1.74% | Mar 31, 2024 |
| Global X Funds | 0.00% | 29,306 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 39,909 | - | - | Feb 29, 2024 |
| Voya INVESTORS TRUST | 0.00% | 32,653 | -2,420 | -6.90% | Mar 31, 2024 |
| Virtus Strategy Trust | 0.00% | 10,437 | - | - | Mar 28, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 138,774 | 24,730 | 21.68% | Jan 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 37,485 | 36 | 0.10% | Jan 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 10,884 | -605 | -5.27% | Mar 31, 2024 |
| SSGA FUNDS | 0.00% | 190 | - | - | Feb 29, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 1,790,144 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 56,751 | -2,926 | -4.90% | Mar 28, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,038 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 621 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 24,400 | -500 | -2.01% | Mar 31, 2024 |
| PRUDENTIAL SERIES FUND | 0.00% | 29,242 | - | - | Mar 28, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 5,384 | - | - | Mar 31, 2024 |
| Chartwell Funds | 0.00% | 6,105 | - | - | Jun 30, 2022 |
| PFM Multi-Manager Series Trust | 0.00% | 200 | - | - | Dec 31, 2023 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 20,414 | -3,654 | -15.18% | Mar 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 17,098 | -8,062 | -32.04% | Jan 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 23,964 | - | - | Mar 28, 2024 |
| THRIVENT MUTUAL FUNDS | 0.00% | 20,279 | - | - | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 4,469 | 349 | 8.47% | Mar 31, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.00% | 4,349 | - | - | Jan 31, 2024 |
Kura Oncology's largest mutual fund holder by % of total assets is "HARTFORD HLS SERIES FUND II INC", owning 245.17K shares, compromising 1.00% of its total assets.
Kura Oncology Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 52 | -69.59% |
| 31 Mar, 24 | 171 | 20.42% |
| 31 Dec, 23 | 142 | 5.97% |
| 30 Sep, 23 | 134 | -12.99% |
| 30 Jun, 23 | 154 | 6.94% |
| 31 Mar, 23 | 144 | -0.69% |
| 31 Dec, 22 | 145 | -3.33% |
| 30 Sep, 22 | 150 | 0.67% |
| 30 Jun, 22 | 149 | 0.68% |
| 31 Mar, 22 | 148 | -6.92% |
| 31 Dec, 21 | 159 | 1.27% |
| 30 Sep, 21 | 157 | -9.25% |
| 30 Jun, 21 | 173 | -0.57% |
| 31 Mar, 21 | 174 | -17.54% |
| 31 Dec, 20 | 211 | 24.85% |
| 30 Sep, 20 | 169 | 22.46% |
| 30 Jun, 20 | 138 | 17.95% |
| 31 Mar, 20 | 117 | -8.59% |
| 31 Dec, 19 | 128 | 11.30% |
| 30 Sep, 19 | 115 | -4.17% |
| 30 Jun, 19 | 120 | 16.50% |
| 31 Mar, 19 | 103 | 8.42% |
| 31 Dec, 18 | 95 | -17.39% |
| 30 Sep, 18 | 115 | 6.48% |
| 30 Jun, 18 | 108 | 11.34% |
| 31 Mar, 18 | 97 | 27.63% |
| 31 Dec, 17 | 76 | 15.15% |
| 30 Sep, 17 | 66 | 57.14% |
| 30 Jun, 17 | 42 | 23.53% |
| 31 Mar, 17 | 34 | 17.24% |
| 31 Dec, 16 | 29 | 11.54% |
| 30 Sep, 16 | 26 | 4.00% |
| 30 Jun, 16 | 25 | 25.00% |
| 31 Mar, 16 | 20 | 42.86% |
| 31 Dec, 15 | 14 | - |
As of 30 Jun 24, 52 institutions are holding Kura Oncology's shares, representing a decrease of -69.59% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 7,841,684 | -90.28% |
| 31 Mar, 24 | 80,714,791 | 2.51% |
| 31 Dec, 23 | 78,740,296 | 4.56% |
| 30 Sep, 23 | 75,309,454 | 0.24% |
| 30 Jun, 23 | 75,132,464 | 3.72% |
| 31 Mar, 23 | 72,441,266 | 3.30% |
| 31 Dec, 22 | 70,128,865 | -1.99% |
| 30 Sep, 22 | 71,550,027 | 4.25% |
| 30 Jun, 22 | 68,634,958 | 2.95% |
| 31 Mar, 22 | 66,665,200 | 4.07% |
| 31 Dec, 21 | 64,056,272 | -3.94% |
| 30 Sep, 21 | 66,680,626 | -1.30% |
| 30 Jun, 21 | 67,561,798 | -1.43% |
| 31 Mar, 21 | 68,544,474 | 5.46% |
| 31 Dec, 20 | 64,995,432 | 21.02% |
| 30 Sep, 20 | 53,704,815 | 2.74% |
| 30 Jun, 20 | 52,271,169 | 31.74% |
| 31 Mar, 20 | 39,676,357 | 2.24% |
| 31 Dec, 19 | 38,808,282 | -3.30% |
| 30 Sep, 19 | 40,134,138 | 4.02% |
| 30 Jun, 19 | 38,582,682 | 20.40% |
| 31 Mar, 19 | 32,046,401 | -1.14% |
| 31 Dec, 18 | 32,415,360 | 7.21% |
| 30 Sep, 18 | 30,235,150 | 2.02% |
| 30 Jun, 18 | 29,637,730 | 25.74% |
| 31 Mar, 18 | 23,570,168 | 20.65% |
| 31 Dec, 17 | 19,535,680 | 0.61% |
| 30 Sep, 17 | 19,417,933 | 79.57% |
| 30 Jun, 17 | 10,813,471 | 4.88% |
| 31 Mar, 17 | 10,310,503 | 4.39% |
| 31 Dec, 16 | 9,877,148 | 1.31% |
| 30 Sep, 16 | 9,749,053 | 4.61% |
| 30 Jun, 16 | 9,319,078 | -8.87% |
| 31 Mar, 16 | 10,226,352 | -0.20% |
| 31 Dec, 15 | 10,246,869 | - |
Kura Oncology (KURA) has 7.84M shares outstanding as of 30 Jun 24, down -90.28% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 9.35% | 0.10% |
| 31 Mar, 24 | 96.20% | 0.93% |
| 31 Dec, 23 | 101.81% | 1.07% |
| 30 Sep, 23 | 97.50% | 0.84% |
| 30 Jun, 23 | 107.65% | 0.96% |
| 31 Mar, 23 | 105.90% | 0.99% |
| 31 Dec, 22 | 103.46% | 0.90% |
| 30 Sep, 22 | 106.97% | 1.01% |
| 30 Jun, 22 | 102.94% | 1.03% |
| 31 Mar, 22 | 100.09% | 1.07% |
| 31 Dec, 21 | 96.54% | 0.96% |
| 30 Sep, 21 | 100.49% | 0.97% |
| 30 Jun, 21 | 101.93% | 0.95% |
| 31 Mar, 21 | 103.51% | 0.85% |
| 31 Dec, 20 | 110.61% | 1.22% |
| 30 Sep, 20 | 95.21% | 0.93% |
| 30 Jun, 20 | 101.24% | 1.33% |
| 31 Mar, 20 | 87.37% | 1.02% |
| 31 Dec, 19 | 92.52% | 1.18% |
| 30 Sep, 19 | 88.71% | 0.90% |
| 30 Jun, 19 | 99.11% | 1.41% |
| 31 Mar, 19 | 83.96% | 0.99% |
| 31 Dec, 18 | 92.11% | 1.44% |
| 30 Sep, 18 | 80.01% | 0.99% |
| 30 Jun, 18 | 89.89% | 1.64% |
| 31 Mar, 18 | 74.05% | 1.66% |
| 31 Dec, 17 | 66.83% | 1.05% |
| 30 Sep, 17 | 79.76% | 2.67% |
| 30 Jun, 17 | 54.64% | 1.95% |
| 31 Mar, 17 | 52.97% | 1.90% |
| 31 Dec, 16 | 52.82% | 1.97% |
| 30 Sep, 16 | 51.72% | 2.05% |
| 30 Jun, 16 | 50.24% | 1.60% |
| 31 Mar, 16 | 56.05% | 1.24% |
| 31 Dec, 15 | 67.14% | - |
As of 30 Jun 24, Kura Oncology is held by 9.35% institutional shareholders, representing a 0.10% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 26 | -72.63% |
| 31 Mar, 24 | 95 | 33.80% |
| 31 Dec, 23 | 71 | -4.05% |
| 30 Sep, 23 | 74 | -9.76% |
| 30 Jun, 23 | 82 | 28.13% |
| 31 Mar, 23 | 64 | -9.86% |
| 31 Dec, 22 | 71 | -2.74% |
| 30 Sep, 22 | 73 | 17.74% |
| 30 Jun, 22 | 62 | -15.07% |
| 31 Mar, 22 | 73 | -5.19% |
| 31 Dec, 21 | 77 | 20.31% |
| 30 Sep, 21 | 64 | -25.58% |
| 30 Jun, 21 | 86 | 1.18% |
| 31 Mar, 21 | 85 | -36.09% |
| 31 Dec, 20 | 133 | 62.20% |
| 30 Sep, 20 | 82 | -7.87% |
| 30 Jun, 20 | 89 | 50.85% |
| 31 Mar, 20 | 59 | -15.71% |
| 31 Dec, 19 | 70 | 11.11% |
| 30 Sep, 19 | 63 | -10.00% |
| 30 Jun, 19 | 70 | 40.00% |
| 31 Mar, 19 | 50 | 19.05% |
| 31 Dec, 18 | 42 | -42.47% |
| 30 Sep, 18 | 73 | 15.87% |
| 30 Jun, 18 | 63 | - |
| 31 Mar, 18 | 63 | 50.00% |
| 31 Dec, 17 | 42 | -16.00% |
| 30 Sep, 17 | 50 | 56.25% |
| 30 Jun, 17 | 32 | 45.45% |
| 31 Mar, 17 | 22 | 100.00% |
| 31 Dec, 16 | 11 | -21.43% |
| 30 Sep, 16 | 14 | - |
| 30 Jun, 16 | 14 | - |
| 31 Mar, 16 | 14 | - |
| 31 Dec, 15 | 14 | - |
26 institutional shareholders have increased their position in KURA stock as of 30 Jun 24 compared to 95 in the previous quarter (a -72.63% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 15 | -68.09% |
| 31 Mar, 24 | 47 | 9.30% |
| 31 Dec, 23 | 43 | 30.30% |
| 30 Sep, 23 | 33 | -19.51% |
| 30 Jun, 23 | 41 | -4.65% |
| 31 Mar, 23 | 43 | -10.42% |
| 31 Dec, 22 | 48 | 11.63% |
| 30 Sep, 22 | 43 | -17.31% |
| 30 Jun, 22 | 52 | 8.33% |
| 31 Mar, 22 | 48 | 20.00% |
| 31 Dec, 21 | 40 | -27.27% |
| 30 Sep, 21 | 55 | 10.00% |
| 30 Jun, 21 | 50 | -1.96% |
| 31 Mar, 21 | 51 | -5.56% |
| 31 Dec, 20 | 54 | - |
| 30 Sep, 20 | 54 | 54.29% |
| 30 Jun, 20 | 35 | -12.50% |
| 31 Mar, 20 | 40 | 14.29% |
| 31 Dec, 19 | 35 | 12.90% |
| 30 Sep, 19 | 31 | - |
| 30 Jun, 19 | 31 | 14.81% |
| 31 Mar, 19 | 27 | -18.18% |
| 31 Dec, 18 | 33 | 26.92% |
| 30 Sep, 18 | 26 | -13.33% |
| 30 Jun, 18 | 30 | 36.36% |
| 31 Mar, 18 | 22 | -4.35% |
| 31 Dec, 17 | 23 | 130.00% |
| 30 Sep, 17 | 10 | 100.00% |
| 30 Jun, 17 | 5 | 25.00% |
| 31 Mar, 17 | 4 | -20.00% |
| 31 Dec, 16 | 5 | -16.67% |
| 30 Sep, 16 | 6 | - |
| 30 Jun, 16 | 6 | - |
| 31 Mar, 16 | 6 | - |
| 31 Dec, 15 | - | - |
15 institutional shareholders have reduced their position in KURA stock as of 30 Jun 24 compared to 47 in the previous quarter (a -68.09% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 52 | -69.59% | 7,841,684 | -90.28% | 9.35% | 0.10% | 26 | -72.63% | 15 | -68.09% |
| 31 Mar, 24 | 171 | 20.42% | 80,714,791 | 2.51% | 96.20% | 0.93% | 95 | 33.80% | 47 | 9.30% |
| 31 Dec, 23 | 142 | 5.97% | 78,740,296 | 4.56% | 101.81% | 1.07% | 71 | -4.05% | 43 | 30.30% |
| 30 Sep, 23 | 134 | -12.99% | 75,309,454 | 0.24% | 97.50% | 0.84% | 74 | -9.76% | 33 | -19.51% |
| 30 Jun, 23 | 154 | 6.94% | 75,132,464 | 3.72% | 107.65% | 0.96% | 82 | 28.13% | 41 | -4.65% |
| 31 Mar, 23 | 144 | -0.69% | 72,441,266 | 3.30% | 105.90% | 0.99% | 64 | -9.86% | 43 | -10.42% |
| 31 Dec, 22 | 145 | -3.33% | 70,128,865 | -1.99% | 103.46% | 0.90% | 71 | -2.74% | 48 | 11.63% |
| 30 Sep, 22 | 150 | 0.67% | 71,550,027 | 4.25% | 106.97% | 1.01% | 73 | 17.74% | 43 | -17.31% |
| 30 Jun, 22 | 149 | 0.68% | 68,634,958 | 2.95% | 102.94% | 1.03% | 62 | -15.07% | 52 | 8.33% |
| 31 Mar, 22 | 148 | -6.92% | 66,665,200 | 4.07% | 100.09% | 1.07% | 73 | -5.19% | 48 | 20.00% |
| 31 Dec, 21 | 159 | 1.27% | 64,056,272 | -3.94% | 96.54% | 0.96% | 77 | 20.31% | 40 | -27.27% |
| 30 Sep, 21 | 157 | -9.25% | 66,680,626 | -1.30% | 100.49% | 0.97% | 64 | -25.58% | 55 | 10.00% |
| 30 Jun, 21 | 173 | -0.57% | 67,561,798 | -1.43% | 101.93% | 0.95% | 86 | 1.18% | 50 | -1.96% |
| 31 Mar, 21 | 174 | -17.54% | 68,544,474 | 5.46% | 103.51% | 0.85% | 85 | -36.09% | 51 | -5.56% |
| 31 Dec, 20 | 211 | 24.85% | 64,995,432 | 21.02% | 110.61% | 1.22% | 133 | 62.20% | 54 | - |
| 30 Sep, 20 | 169 | 22.46% | 53,704,815 | 2.74% | 95.21% | 0.93% | 82 | -7.87% | 54 | 54.29% |
| 30 Jun, 20 | 138 | 17.95% | 52,271,169 | 31.74% | 101.24% | 1.33% | 89 | 50.85% | 35 | -12.50% |
| 31 Mar, 20 | 117 | -8.59% | 39,676,357 | 2.24% | 87.37% | 1.02% | 59 | -15.71% | 40 | 14.29% |
| 31 Dec, 19 | 128 | 11.30% | 38,808,282 | -3.30% | 92.52% | 1.18% | 70 | 11.11% | 35 | 12.90% |
| 30 Sep, 19 | 115 | -4.17% | 40,134,138 | 4.02% | 88.71% | 0.90% | 63 | -10.00% | 31 | - |
| 30 Jun, 19 | 120 | 16.50% | 38,582,682 | 20.40% | 99.11% | 1.41% | 70 | 40.00% | 31 | 14.81% |
| 31 Mar, 19 | 103 | 8.42% | 32,046,401 | -1.14% | 83.96% | 0.99% | 50 | 19.05% | 27 | -18.18% |
| 31 Dec, 18 | 95 | -17.39% | 32,415,360 | 7.21% | 92.11% | 1.44% | 42 | -42.47% | 33 | 26.92% |
| 30 Sep, 18 | 115 | 6.48% | 30,235,150 | 2.02% | 80.01% | 0.99% | 73 | 15.87% | 26 | -13.33% |
| 30 Jun, 18 | 108 | 11.34% | 29,637,730 | 25.74% | 89.89% | 1.64% | 63 | - | 30 | 36.36% |
| 31 Mar, 18 | 97 | 27.63% | 23,570,168 | 20.65% | 74.05% | 1.66% | 63 | 50.00% | 22 | -4.35% |
| 31 Dec, 17 | 76 | 15.15% | 19,535,680 | 0.61% | 66.83% | 1.05% | 42 | -16.00% | 23 | 130.00% |
| 30 Sep, 17 | 66 | 57.14% | 19,417,933 | 79.57% | 79.76% | 2.67% | 50 | 56.25% | 10 | 100.00% |
| 30 Jun, 17 | 42 | 23.53% | 10,813,471 | 4.88% | 54.64% | 1.95% | 32 | 45.45% | 5 | 25.00% |
| 31 Mar, 17 | 34 | 17.24% | 10,310,503 | 4.39% | 52.97% | 1.90% | 22 | 100.00% | 4 | -20.00% |
| 31 Dec, 16 | 29 | 11.54% | 9,877,148 | 1.31% | 52.82% | 1.97% | 11 | -21.43% | 5 | -16.67% |
| 30 Sep, 16 | 26 | 4.00% | 9,749,053 | 4.61% | 51.72% | 2.05% | 14 | - | 6 | - |
| 30 Jun, 16 | 25 | 25.00% | 9,319,078 | -8.87% | 50.24% | 1.60% | 14 | - | 6 | - |
| 31 Mar, 16 | 20 | 42.86% | 10,226,352 | -0.20% | 56.05% | 1.24% | 14 | - | 6 | - |
| 31 Dec, 15 | 14 | - | 10,246,869 | - | 67.14% | - | 14 | - | - | - |
Kura Oncology Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Kura Oncology's stock was made by Bair Teresa Brophy on May 20 2024, selling 2,615 shares at $22.15 per share (valued at $57.92K).
Kura Oncology Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 6 | 1 | 600.00% |
| Q1 2024 | 11 | 9 | 122.22% |
| Q4 2023 | - | 2 | - |
| Q3 2023 | 1 | - | - |
| Q2 2023 | 9 | 6 | 150.00% |
| Q1 2023 | 8 | 6 | 133.33% |
| Q4 2022 | 1 | 2 | 50.00% |
| Q3 2022 | 1 | 4 | 25.00% |
| Q2 2022 | 10 | - | - |
| Q1 2022 | 11 | 3 | 366.67% |
| Q4 2021 | 1 | - | - |
| Q3 2021 | 2 | - | - |
| Q2 2021 | 8 | - | - |
| Q1 2021 | 7 | 2 | 350.00% |
| Q4 2020 | 6 | 13 | 46.15% |
| Q3 2020 | 16 | 33 | 48.48% |
| Q2 2020 | 6 | - | - |
| Q1 2020 | 8 | 2 | 400.00% |
| Q4 2019 | 3 | - | - |
| Q3 2019 | 2 | 2 | 100.00% |
6 total buy trades, and 1 total sell trades (buy/sell ratio of 6.00%) were made by Kura Oncology's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 1 | - |
| Q1 2024 | - | 9 | - |
| Q4 2023 | - | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | 1 | - | - |
| Q1 2023 | - | 6 | - |
| Q4 2022 | - | 1 | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | 1 | - |
| Q4 2020 | - | 7 | - |
| Q3 2020 | - | 17 | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | - | 1 | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Kura Oncology's stocks.
Kura Oncology Peer Ownership
| Ticker | Company |
|---|---|
| GRCL | Gracell Biotechnologies Inc. |
| ZNTL | Zentalis Pharmaceuticals, Inc. |
| KALV | KalVista Pharmaceuticals, Inc. |
| KNSA | Kiniksa Pharmaceuticals, Ltd. |
| VRDN | Viridian Therapeutics, Inc. |
| MRUS | Merus N.V. |
| LRMR | Larimar Therapeutics, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| ERAS | Erasca, Inc. |
| CERE | Cerevel Therapeutics Holdings, Inc. |
| COGT | Cogent Biosciences, Inc. |
| REPL | Replimune Group, Inc. |
| SNDX | Syndax Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| CRNX | Crinetics Pharmaceuticals, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| PTGX | Protagonist Therapeutics, Inc. |
KURA Ownership FAQ
Who Owns Kura Oncology?
Kura Oncology is owned by institutional shareholders (9.35%), insiders (1.07%), and public (89.59%). The largest institutional shareholder of Kura Oncology is SUVRETTA CAPITAL MANAGEMENT, LLC (8.43% of total shares) and the top mutual fund owner is HARTFORD HLS SERIES FUND II INC (1.00% of total shares).
Who are the major institutional shareholders of Kura Oncology?
Kura Oncology's major institutional shareholders are SUVRETTA CAPITAL MANAGEMENT, LLC, BLACKROCK INC., ECOR1 CAPITAL, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), and PARADIGM BIOCAPITAL ADVISORS LP. The top five shareholders own together 35.51% of the company's share outstanding.
How many Kura Oncology shareholders are there?
As of Jun 2024, there are 52 institutional shareholders of Kura Oncology.
What percentage of Kura Oncology is owned by SUVRETTA CAPITAL MANAGEMENT, LLC?
SUVRETTA CAPITAL MANAGEMENT, LLC owns 7.07M shares of Kura Oncology, representing 8.43% of the company's total shares outstanding, valued at $145.56M (as of Jun 2024).
What percentage of Kura Oncology is owned by BLACKROCK INC?
As of Jun 2024, BLACKROCK INC holds 6.97M shares of Kura Oncology (KURA), compromising 8.30% of the company, valued at $143.43M.
What percentage of Kura Oncology is owned by ECOR1 CAPITAL, LLC?
ECOR1 CAPITAL, LLC is the third largest holder of Kura Oncology. The company owns 5.81M of the company's shares outstanding (worth $119.56M).